ERBB2 c.3245G>C ;(p.G1082A)

Variant ID: 17-37883633-G-C

NM_004448.2(ERBB2):c.3245G>C;(p.G1082A)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.

Breast Cancer Research And Treatment
Leyland-Jones, Brian B; Gray, Kathryn P KP; Abramovitz, Mark M; Bouzyk, Mark M; Young, Brandon B; Long, Bradley B; Kammler, Roswitha R; Dell'Orto, Patrizia P; Biasi, Maria Olivia MO; Thürlimann, Beat B; Harvey, Vernon V; Neven, Patrick P; Arnould, Laurent L; Maibach, Rudolf R; Price, Karen N KN; Coates, Alan S AS; Goldhirsch, Aron A; Gelber, Richard D RD; Pagani, Olivia O; Viale, Giuseppe G; Rae, James M JM; Regan, Meredith M MM; ,
Publication Date: 2015-12

Variant appearance in text: HER2: G1082A
PubMed Link: 26590813
Variant Present in the following documents:
  • Main text
View BVdb publication page